EP Patent

EP1439829B1 — 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung

Assigned to Gruenenthal GmbH · Expires 2005-09-07 · 21y expired

What this patent protects

Patent listed against Keppra.

Drugs covered by this patent

Keppra (levetiracetam) · Generic (originally UCB Pharma)

Patent Metadata

Patent number: EP1439829B1
Jurisdiction: EP
Classification: —
Expires: 2005-09-07
Drug substance claim: No
Drug product claim: No
Assignee: Gruenenthal GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.